No Data
No Data
J.P. Morgan Maintains Hologic(HOLX.US) With Buy Rating, Cuts Target Price to $92
Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women
Hologic Analyst Ratings
Asia Cervical Cancer Screening Market Forecast Report 2024-2032, Featuring Profiles of Abbott Laboratories, Hologic, Becton, Siemens, Roche Diagnostics, Quest Diagnostics and Cardinal Health
Hologic's Deal For Gynesonics Seen As Good Fit -- Market Talk
Needham Maintains Hologic(HOLX.US) With Buy Rating, Maintains Target Price $90
No Data
No Data